Provided by Tiger Fintech (Singapore) Pte. Ltd.

LUYE PHARMA

3.210
-0.030-0.93%
Volume:29.36M
Turnover:94.39M
Market Cap:12.82B
PE:23.37
High:3.250
Open:3.210
Low:3.150
Close:3.240
52wk High:4.490
52wk Low:1.670
Shares:4.00B
HK Float Shares:4.00B
Volume Ratio:1.35
T/O Rate:0.73%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.137
ROE:3.68%
ROA:2.41%
PB:0.80
PE(LYR):23.37
PS:1.90

Loading ...

Market Participants Recognise Luye Pharma Group Ltd.'s (HKG:2186) Earnings

Simply Wall St.
·
Nov 11

HK Stock Connect Shareholding Changes | Oct 28

Stock News
·
Oct 28

Does the Recent 7.7% Price Jump Signal a New Outlook for Luye Pharma Group in 2025?

Simply Wall St.
·
Oct 07

Is Luye Pharma Group (SEHK:2186) Overvalued? A Fresh Look at Its Current Share Price and P/E Ratio

Simply Wall St.
·
Oct 03

Shandong Boan Biotechnology Reports 8.4% Rise in Revenue to RMB393.4 Million and Net Profit of RMB20.5 Million for H1 2025

Reuters
·
Sep 29

Huaan Securities Maintains "Buy" Rating on LUYE PHARMA, Optimistic About Global Sales Platform Capabilities

Stock News
·
Sep 29

Evaluating Luye Pharma Group (SEHK:2186): Is Its Current Valuation Justified by Recent Performance?

Simply Wall St.
·
Sep 22

Luye Pharma Group (SEHK:2186): Examining Valuation After Recent Stock Volatility

Simply Wall St.
·
Sep 14

LUYE PHARMA (02186) Issues 52.92 Million Shares Due to Convertible Bond Conversion

Stock News
·
Sep 09

Luye Pharma Group's H1 Profit Falls 19%

MT Newswires Live
·
Aug 29

Stock Track | Luye Pharma Soars 5.69% Following Strong H1 2025 Financial Results

Stock Track
·
Aug 29

LUYE PHARMA (02186) Reports Interim Results with Shareholders' Profit of RMB313 Million, Down 19.33% YoY

Stock News
·
Aug 28

BRIEF-Luye Pharma Posts HY Profit Attributable Of RMB312.9 Mln

Reuters
·
Aug 28

Luye Pharma - Profit Attributable for Six Months RMB312.9 Mln

THOMSON REUTERS
·
Aug 28

Luye Pharma Group H1 Gross Margin 67.8%

THOMSON REUTERS
·
Aug 28

Kale Asset Holding Ltd Reduces Stake in LUYE PHARMA (02186) by 11.25 Million Shares at Average Price of HKD 3.76 Per Share

Stock News
·
Aug 22

LUYE PHARMA (02186) Issues 52.919 Million Shares Due to Convertible Bond Conversion

Stock News
·
Aug 20

Luye Pharma Completes Patient Enrollment for Phase 3 GAD Trial

MT Newswires Live
·
Aug 18

LUYE PHARMA (02186): Ruoxinlin® Phase III Clinical Trial for Generalized Anxiety Disorder Completes Patient Enrollment in China

Stock News
·
Aug 18

Luye Pharma Group Ltd. Announces Conversion of Tranche A Bonds Worth US$10 Million

Reuters
·
Aug 01